“Our estimate suggests an expected net harm from boosters in this young adult age group, whereby the negative outcomes of all severe adverse events and hospitalizations may on average outweigh the expected benefits in terms of Covid-19 hospitalizations averted,” say study authors from Oxford, Harvard, and Johns Hopkins.